Shopping Cart
- Remove All
- Your shopping cart is currently empty
Ilorasertib hydrochloride (ABT-348 hydrochloride) is an ATP-competitive multitargeted kinase inhibitor, which inhibits Aurora C, Aurora B, and Aurora A (IC50s: 1 nM, 7 nM, 120 nM). It also suppresses RET tyrosine kinase, PDGFRβ, and Flt1 (IC50s: 7 nM, 3 nM, and 32 nM).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $53 | In Stock |
Description | Ilorasertib hydrochloride (ABT-348 hydrochloride) is an ATP-competitive multitargeted kinase inhibitor, which inhibits Aurora C, Aurora B, and Aurora A (IC50s: 1 nM, 7 nM, 120 nM). It also suppresses RET tyrosine kinase, PDGFRβ, and Flt1 (IC50s: 7 nM, 3 nM, and 32 nM). |
Targets&IC50 | CSF1R:3 nM, Aurora C:1 nM, VEGFR1:1 nM, Aurora A:120 nM, c-Kit:20 nM, FLT3:1 nM, PDGFRβ:13 nM, PDGFRα:11 nM, Aurora B:7 nM, Aurora B (Y156H):12 nM, VEGFR3:43 nM, VEGFR2:2 nM |
Alias | ABT-348 hydrochloride |
Molecular Weight | 525 |
Formula | C25H22ClFN6O2S |
Cas No. | 1847485-91-9 |
Smiles | Cl.Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12 |
Relative Density. | 1.31g/cm3 |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
Solubility Information | DMSO: 41.67 mg/mL (79.37 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.